Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05610345 · ClinicalTrials.gov registry record · NA
The Effect of Placental Cord Drainage on Postpartum Blood Loss
A NA study, sponsored by University of Tennessee.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
NCT05610345: Completed NA study, sponsored by University of Tennessee.
NCT05610345 is a NA study that has completed, run by University of Tennessee. The registered enrollment target is 71 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05610345, a NA study, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
Study Summary
To determine if placental cord drainage decreases the blood loss after spontaneous vaginal delivery
Primary Outcome
Total Volume in Underbuttocks Drape - Initial Volume in Drape (amniotic fluid etc) + blood in laparotomy sponges
Interventions
- PROCEDURE Placental Blood Drainage
- PROCEDURE Placenta Blood Not Drained
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2022-11-12 |
| Est. Completion | 2023-06-01 |
| Phase | NA |
What the finished NCT05610345 record still lists
NCT05610345 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Placental Blood Drainage is the first listed.
NCT05610345 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05610345 about?
NCT05610345 is a clinical study titled "The Effect of Placental Cord Drainage on Postpartum Blood Loss". To determine if placental cord drainage decreases the blood loss after spontaneous vaginal delivery
What is the current status of trial NCT05610345?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2022-11-12. Estimated completion is 2023-06-01.
What interventions are being tested in trial NCT05610345?
The interventions under investigation include: Placental Blood Drainage (PROCEDURE), Placenta Blood Not Drained (PROCEDURE).
Who is sponsoring clinical trial NCT05610345?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05610345's enrollment target sits among peer trials
71 1102nd of 2000 higher than 898 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI